Bioequivalence and Bioavailability Forum

BE study for Minoxidil jag009 2025-02-20 06:24
- FDA PSGs: Alternative approach Helmut 2025-02-20 10:44
- BE study for Minoxidil drgunasakaran1 2025-02-21 00:57
  - BE study for Minoxidil jag009 2025-03-01 03:20
    - BE study for Minoxidil ElMaestro 2025-03-01 20:29

Question about Williams Design Bebac user 2025-02-25 20:30

different ranks/levels of William design? Shuanghe 2025-02-12 00:46
- different ranks/levels of William design? BEQool 2025-02-19 11:34
- "ranking" William designs mittyri 2025-02-19 21:08
  - "ranking" William designs vezz 2025-02-20 14:23
  - "ranking" William designs Shuanghe 2025-02-23 11:47

Bioequivalence studies for GCC submission professionalr 2025-01-30 23:00
- Bioequivalence studies for GCC submission drgunasakaran1 2025-01-31 03:20

Stratified randomisation in parallel BE studies and ANOVA model BEQool 2024-11-14 12:42
- Stratified randomisation in parallel BE studies BEQool 2025-01-27 08:03

Tripolidine BE Study – Malaysian RLD professionalr 2025-01-21 22:19
- ASEAN BE Guideline Helmut 2025-01-22 11:40

Interim Safety Analysis or Re-Screening professionalr 2025-01-09 22:56
- Interim Safety Analysis or Re-Screening drgunasakaran1 2025-01-10 00:01

Do regulatory agencies accept steady-state equivalence studies? libaiyi 2024-12-04 08:34
- HVD(P)s: steady state = history Helmut 2024-12-04 09:37
  - HVD(P)s: steady state = history libaiyi 2024-12-04 09:52
    - HVD(P)s: steady state = history dshah 2024-12-05 07:22
- Do regulatory agencies accept steady-state equivalence studies? xtianbadillo 2024-12-16 20:59
  - steady-state in patients Helmut 2024-12-17 09:45
    - steady-state in patients qualityassurance 2025-01-09 10:59

Possible reasons for group effect GM 2019-07-20 07:36
- Group “effect” Helmut 2019-07-20 14:02
- Possible reasons for group effect ElMaestro 2019-07-20 19:20
  - Possible reasons for group effect GM 2019-07-23 06:23
    - “Group-by-Treatment Interaction” Helmut 2019-07-23 10:32
      - “Group-by-Treatment Interaction” BEQool 2024-10-22 12:39
        
        “Group-by-Treatment Interaction” Helmut 2024-10-22 12:47
        
        OT: A choice between mittyri 2024-10-22 16:03
        
        OT: A choice between BEQool 2024-10-23 11:02
        
        OT: A choice between Helmut 2024-10-23 11:58
        
        OT: A choice between BEQool 2024-10-23 13:17
        
        OT: A choice between Helmut 2024-10-23 13:22
        Groups: Overlapping CIs Helmut 2024-11-03 11:36
        
        Groups: Overlapping CIs BEQool 2024-11-05 09:14
        
        Groups: Overlapping CIs Helmut 2024-11-05 10:12
        
        Groups: Overlapping CIs BEQool 2024-11-06 07:44
        
        Groups: (Hardly‽) overlapping CIs Helmut 2024-11-21 13:20
        
        Groups: (Hardly‽) overlapping CIs BEQool 2024-11-22 12:32
        
        Groups: (Hardly‽) overlapping CIs Helmut 2024-11-22 12:58
        Multiplicity? Helmut 2024-11-23 13:05
        
        Groups BEQool 2024-11-26 08:15

PK Sampling Time Points - SR Formulation TitusBen 2024-10-17 05:40
- PK Sampling Time Points - SR Formulation Helmut 2024-10-17 10:56
  - PK Sampling Time Points - SR Formulation TitusBen 2024-10-18 06:24
    - PK Sampling Time Points - DR Formulation Helmut 2024-10-18 09:16
      - PK Sampling Time Points - DR Formulation TitusBen 2024-10-18 16:45
        
        lag-time – another round Helmut 2024-10-19 08:20

Sulfasalazine: Bioequivalence Study ramesh_7779 2011-06-25 10:54
- Sulfasalazine: Bioequivalence Study Helmut 2011-06-25 13:18
  - Sulfasalazine: Bioequivalence Study dshah 2024-10-15 06:05
    - Sulfasalazine: Sources Helmut 2024-10-15 09:03
      - Sulfasalazine: Sources dshah 2024-10-16 06:16

risperidone AND water Bebac user 2024-09-04 18:51
- ODT vs IR Helmut 2024-09-05 11:57
- risperidone AND water dshah 2024-09-06 06:15

Compound highly variable Laura Carreiras 2024-08-28 08:20
- Always full (!) replicate pilot for reference-scaling Helmut 2024-08-28 11:25
  - Always full (!) replicate pilot for reference-scaling Laura Carreiras 2024-09-02 13:52

Leuprolide 1 month product shelf life Achievwin 2024-08-27 02:47

Oxcarbazepine Tablet Study design AB661 2024-07-13 09:02
- ABE or ABEL for Health Canada Helmut 2024-07-14 12:17
- Oxcarbazepine Tablet Study design jag009 2024-07-23 19:50
  - Health Canada ABEL Helmut 2024-07-24 09:06
  - Oxcarbazepine Tablet Study design AB661 2024-08-24 11:00
    - Oxcarbazepine Tablet Study design Helmut 2024-08-24 12:19

Admin contact
23,424 posts in 4,927 threads, 1,668 registered users;
85 visitors (0 registered, 85 guests [including 43 identified bots]).
Forum time: 15:11 CEST (Europe/Vienna)

No matter what side of the argument you are on,
you always find people on your side
that you wish were on the other. Thomas Berger

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC

Ing. Helmut Schütz